TARA Founder Uses Biowire™ and Neural Networks for Screening

September 18, 2017 | News

TARA Founder Uses Biowire™ and Neural Networks for Screening

September 18, 2017. Dr. Milica Radisic's lab at the University of Toronto just published a paper on using Biowire™ technology to screen kinase inhibitors. Kinase inhibitors are cancer targeting drugs, though certain ones have been identified to have cardiotoxic effects. The Radisic lab tested a set of compounds on a 2D screening assay, used an artificial neural network to select kinase inhibitors of specific interest, and then tested the selected compounds on 3D Biowire™ tissues. The research is published in Scientific Reports.

Contact

As a result, currently 8 out of 9 drugs tested for cardiotoxicity fail in clinical trials, after spending significant time.

TARA
430 East 29th Street
Suite #1015
New York, NY 10016
USA
info@tarabiosystems.com